ARTICLE | Company News
Genencor, Phogen in vaccine deal
August 13, 2001 7:00 AM UTC
Phogen ( Cambridge, U.K.), a joint venture between Xenova (LSE:XEN; XNVA) and Marie Curie Cancer Care, granted GCOR an exclusive worldwide license to its VP22 drug delivery technology for vaccines to ...